1. Infrapatellar fat pad (IPFP) glucocorticoid injections do not significantly reduce pain or effusion volume compared to placebo in knee...
1. Tofacitinib significantly improves patient-reported outcomes compared to placebo in the management of juvenile idiopathic arthritis (JIA). Evidence Rating Level:...
1. Single C-reactive protein (CRP) measurements can be highly misleading due to large within-person variability, especially at higher values; repeat...
1. Increased gut inflammation, as measured by fecal calprotectin, is significantly associated with greater structural spinal damage in axial spondyloarthritis...
1. In patients with inflammatory rheumatic diseases (IRD), digital psychological intervention was associated with improved psychological outcomes and quality of...
1. In this retrospective cohort study involving patients with rheumatoid arthritis on disease-modifying antirheumatic drugs, long-term routine laboratory toxicity monitoring...
1. Medical cannabis has a high discontinuation rate among patients with chronic musculoskeletal pain, particularly in the first few months,...
1. Hydroxychloroquine plus prednisolone reduced the 12-month risk of the composite cardiovascular outcome by 72 percent compared with prednisolone alone....
1. In this randomized controlled trial, rituximab was not superior to standard treatment in inducing remission in patients with eosinophilic...
1. Gabapentin use was associated with a 29% increased risk of dementia and 85% increased risk of mild cognitive impairment...
